IMCC Im Cannabis Corp

USD 0.60 -0.01 -1.399177
Icon

Im Cannabis Corp (IMCC) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.599

-0.01 (-1.40)%

USD 8.17M

0.11M

N/A

N/A

Icon

IMCC

Im Cannabis Corp (USD)
COMMON STOCK | NSD
USD 0.60
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 8.17M

N/A

USD 0.60

Im Cannabis Corp (IMCC) Stock Forecast

N/A

Based on the Im Cannabis Corp stock forecast from 0 analysts, the average analyst target price for Im Cannabis Corp is not available over the next 12 months. Im Cannabis Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Im Cannabis Corp is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Im Cannabis Corp’s stock price was USD 0.599. Im Cannabis Corp’s stock price has changed by +3.28% over the past week, +40.28% over the past month and -13.06% over the last year.

No recent analyst target price found for Im Cannabis Corp
No recent average analyst rating found for Im Cannabis Corp

Company Overview Im Cannabis Corp

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the ...Read More

https://www.imcannabis.com

Kibbutz Glil Yam, Tel Aviv, Israel, 4690500

95

December

USD

USA

Adjusted Closing Price for Im Cannabis Corp (IMCC)

Loading...

Unadjusted Closing Price for Im Cannabis Corp (IMCC)

Loading...

Share Trading Volume for Im Cannabis Corp Shares

Loading...

Compare Performance of Im Cannabis Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for IMCC

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Im Cannabis Corp (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZTS
Zoetis Inc -0.96 (-0.66%) USD66.94B 28.90 19.98

ETFs Containing IMCC

Symbol Name IMCC's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Im Cannabis Corp (IMCC) Stock

Stock Target Advisor's fundamental analysis for Im Cannabis Corp's stock is Bearish.

Unfortunately we do not have enough data on IMCC's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on IMCC's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on IMCC's stock to indicate if its overvalued.

The last closing price of IMCC's stock was USD 0.60.

The most recent market capitalization for IMCC is USD 8.17M.

Unfortunately we do not have enough analyst data on IMCC's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Im Cannabis Corp's stock.

As per our most recent records Im Cannabis Corp has 95 Employees.

Im Cannabis Corp's registered address is Kibbutz Glil Yam, Tel Aviv, Israel, 4690500. You can get more information about it from Im Cannabis Corp's website at https://www.imcannabis.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...